JP2003530311A5 - - Google Patents

Download PDF

Info

Publication number
JP2003530311A5
JP2003530311A5 JP2001537346A JP2001537346A JP2003530311A5 JP 2003530311 A5 JP2003530311 A5 JP 2003530311A5 JP 2001537346 A JP2001537346 A JP 2001537346A JP 2001537346 A JP2001537346 A JP 2001537346A JP 2003530311 A5 JP2003530311 A5 JP 2003530311A5
Authority
JP
Japan
Prior art keywords
seq
group
peptide
formula
wqeweqkitall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2001537346A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003530311A (ja
Filing date
Publication date
Priority claimed from US09/349,205 external-priority patent/US6469136B1/en
Application filed filed Critical
Publication of JP2003530311A publication Critical patent/JP2003530311A/ja
Publication of JP2003530311A5 publication Critical patent/JP2003530311A5/ja
Ceased legal-status Critical Current

Links

JP2001537346A 1999-07-07 2000-07-05 ペプチド合成の方法および組成物 Ceased JP2003530311A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/349,205 1999-07-07
US09/349,205 US6469136B1 (en) 1999-07-07 1999-07-07 Methods and composition for peptide synthesis
PCT/US2000/035725 WO2001034635A2 (en) 1999-07-07 2000-07-05 Methods and compositions for peptide synthesis

Publications (2)

Publication Number Publication Date
JP2003530311A JP2003530311A (ja) 2003-10-14
JP2003530311A5 true JP2003530311A5 (enExample) 2007-08-30

Family

ID=23371340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001537346A Ceased JP2003530311A (ja) 1999-07-07 2000-07-05 ペプチド合成の方法および組成物

Country Status (17)

Country Link
US (2) US6469136B1 (enExample)
EP (1) EP1372686B1 (enExample)
JP (1) JP2003530311A (enExample)
KR (1) KR100631874B1 (enExample)
CN (1) CN1267449C (enExample)
AR (1) AR024686A1 (enExample)
AT (1) ATE288278T1 (enExample)
AU (1) AU4133701A (enExample)
BR (1) BR0012249A (enExample)
CA (1) CA2378086A1 (enExample)
DE (1) DE60017955T2 (enExample)
DK (1) DK1372686T3 (enExample)
ES (1) ES2236043T3 (enExample)
MX (1) MXPA02000021A (enExample)
PT (1) PT1372686E (enExample)
TW (1) TWI237640B (enExample)
WO (1) WO2001034635A2 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
SK782002A3 (en) * 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
NZ537493A (en) * 2002-07-24 2007-05-31 Hoffmann La Roche Pegylated T1249 polypeptide
US20040158037A1 (en) * 2003-02-12 2004-08-12 Bohling James Charles Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and biologically active substances and therapeutics produced therewith
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
ATE497783T1 (de) * 2003-05-06 2011-02-15 Syntonix Pharmaceuticals Inc Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten
DE602004017057D1 (de) * 2003-12-31 2008-11-20 Hoffmann La Roche Verfahren und systeme zur rückgewinnung von peptiden
EP1701976A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Peptide synthesis and deprotection with co-solvent
WO2005063792A2 (en) * 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Methods for recovering cleaved peptide from a support
EP1701971A2 (en) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Peptide synthesis using decanting filter
EP1701969B1 (en) * 2003-12-31 2007-10-24 F.Hoffmann-La Roche Ag Process for peptide synthesis using a reduced amount of deprotection agent
CN101132812A (zh) * 2004-03-15 2008-02-27 阿拉巴马耐科塔医药公司 Hiv进入抑制剂的聚合物基组合物和结合物
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments
CA2592438C (en) * 2004-12-30 2013-09-03 F.Hoffmann-La Roche Ag Synthesis of peptide t-20 using peptide intermediate fragments
WO2006069779A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Preparing of peptides with excellent solubility
WO2006069697A1 (en) * 2004-12-30 2006-07-06 F. Hoffmann-La Roche Ag Colorimetrically assessing peptide characteristics
WO2006105199A2 (en) * 2005-03-30 2006-10-05 Trimeris, Inc. Compositions and methods for synthesis of peptide and related conjugate
TW200745163A (en) 2006-02-17 2007-12-16 Syntonix Pharmaceuticals Inc Peptides that block the binding of IgG to FcRn
CA2651070A1 (en) 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101195653B (zh) * 2006-12-08 2010-05-12 吉尔生化（上海）有限公司 亮丙瑞林的固液合成法
JP2010535788A (ja) * 2007-08-09 2010-11-25 シントニックス・ファーマシューティカルズ・インコーポレーテッド 免疫調節性ペプチド
BRPI0817697A2 (pt) * 2007-09-25 2015-04-07 Trimeris Inc Método de síntese de um peptídeo, conjunto de fragmentos de peptídeo, e, peptídeo
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
AU2008334783A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
WO2010014909A1 (en) * 2008-08-01 2010-02-04 Syntonix Pharmaceuticals, Inc. Immunomodulatory peptides
SI2591006T1 (sl) 2010-07-09 2019-10-30 Bioverativ Therapeutics Inc Enoverižne molekule, ki jih lahko obdelujemo in polipeptidi izdelani z njihovo uporabo
CN102268065A (zh) * 2011-06-23 2011-12-07 成都圣诺科技发展有限公司 氨基保护丝氨酸寡肽及其制备方法和用途
CN102603869B (zh) * 2012-03-27 2013-03-27 西安华澳丽康生物工程有限公司 六胜肽的合成方法
TWI745671B (zh) 2013-03-15 2021-11-11 美商百歐維拉提夫治療公司 因子ｉｘ多肽調配物
AU2014234400B2 (en) 2013-03-21 2017-11-16 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
DK2976325T3 (en) 2013-03-21 2017-06-06 Sanofi Aventis Deutschland SYNTHESIS OF PEPTIDE PRODUCTS CONTAINING CYCLIC IMID
CN108572171A (zh) * 2017-03-10 2018-09-25 江苏金斯瑞生物科技有限公司 一种检测哌啶残留的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002505A1 (en) * 1992-07-20 1994-02-03 Duke University Compounds which inhibit hiv replication
CA2150371C (en) 1992-12-11 2002-09-17 Dov Borovsky Materials and methods for control of pests
US6479055B1 (en) 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
EP0708659A4 (en) 1993-06-07 2000-08-23 Genentech Inc HIV ENVELOPE POLYPEPTIDE
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
DE69926061T2 (de) * 1998-03-23 2006-06-01 Trimeris Inc. Verfahren und zusammensetzungen zur peptidsynthese (t-20)
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6217666B1 (en) 1998-08-31 2001-04-17 Danieli Technology, Inc. Countercurrent reduction of oxides on moving metal

Similar Documents

Publication Publication Date Title
JP2003530311A5 (enExample)
JP4405594B2 (ja) 改良型固相ペプチド合成及びかかる合成において利用するための試薬
JP2002507576A5 (enExample)
FI90780B (fi) Tekohartsi
EP2873677B1 (en) Method of producing self-assembling peptide derivative
CA2324348A1 (en) Methods and compositions for peptide synthesis
CA2212052C (en) N.alpha.-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids
EP0274999A2 (en) Resin support for solid phase peptide synthesis
Nishiuchi et al. Nin-Cyclohexyloxycarbonyl group as a new protecting group for tryptophan
Limal et al. Solid-phase synthesis of N, N′-unsymmetrically substituted ureas: application to the synthesis of carbaza peptides
CA1274340A (en) Resin support for solid phase peptide synthesis
JP3800245B2 (ja) 新規な機能性ペプチド核酸およびその製法
WO1993005065A1 (en) Preparation of peptides by a solid-phase synthesis and intermediates therefor
KR101171095B1 (ko) 루프로라이드의 제조방법
WO1999007874A1 (en) Process for producing lh-rh derivatives
CN110343147B (zh) 艾替班特的合成方法
Athanassopoulos et al. Model studies towards the applicability of the readily available (S)-N-tritylaspartic anhydride in the synthesis of amino acids and peptides
Pande et al. Solid‐phase peptide synthesis on a novel hydrogenolysable linker–resin combination
CN120574284A (zh) 一种三肽-29的合成方法
TWI290547B (en) Novel functional peptide nucleic acid and process for producing the same
RU2218347C2 (ru) Способ получения тридекапептида и пентапептид для его получения
JP2948261B2 (ja) ペプチドモノマーの合成法
HU197030B (en) Process for producing new hexapeptides and pharmaceuticals comprising same
TW200413286A (en) Novel functional peptide nucleic acid and process for producing the same
WO1995034314A1 (en) A resin for use in solid phase synthesis for the preparation of peptide hydrazides